Diabetes startup mySugr raised $4.8 million from both new and existing investors. New investors participating in the round included Basel, Switzerland-based Roche Ventures and iSeed Ventures from San Francisco and Beijing; with existing partner XLHealth also participating in the round. The fresh capital will go towards the company’s continued international growth.

Vienna-based mySugr makes it easier to live with diabetes, offering its popular mySugr Logbook app, and the mySugr Academy diabetes education platform.

“We are very excited that these two fantastic investors have joined us in our mission: To make diabetes suck less,” said Frank Westermann, CEO of mySugr. “Roche Ventures brings with it many decades of diabetes industry know-how and iSeed Ventures has expertise in the digital health market with access to the United States and China, two of the most important global diabetes markets.”

This is the first time Roche Ventures has invested in the digital health segment. Apparently, they were impressed with mySugr’s “unmatched understanding, precise problem solving, and beautiful solutions” that is spanning the entire organization.

Diabetes is one of the world’s largest health problems. More than 387 million people live with diabetes and the numbers continue to rise rapidly.